Heparin Bolus for Unstable Angina
Yes, you must administer a weight-based bolus of unfractionated heparin for unstable angina (NSTE-ACS), followed by continuous infusion, as parenteral anticoagulation is a Class I recommendation in all current guidelines. 1
Initial Bolus Dosing
The recommended initial bolus is 60-70 IU/kg (maximum 4000-5000 IU) intravenously, followed immediately by a continuous infusion of 12-15 IU/kg/hour (maximum 1000 IU/hour). 2, 3 The 2020 ESC guidelines specify a weight-adjusted bolus during PCI of 70-100 IU/kg, or 50-70 IU/kg when combined with a GP IIb/IIIa inhibitor. 1
Rationale and Evidence Base
Parenteral anticoagulation is recommended for all patients with NSTE-ACS at the time of diagnosis, in addition to antiplatelet therapy, according to both ischemic and bleeding risk profiles (Class I, Level A). 1
Unfractionated heparin remains the standard of care for NSTE-ACS patients due to its favorable risk-benefit profile. 1
The combination of aspirin plus heparin shows a modest but clinically meaningful reduction in death or MI compared to aspirin alone (OR 0.74,95% CI 0.5-1.09), though this did not reach statistical significance in pooled analyses. 1, 4
Heparin is considered fundamental therapy when given in conjunction with antiplatelet agents (Class IA). 1
Monitoring and Target
Target activated partial thromboplastin time (aPTT) of 50-70 seconds (some guidelines specify 60-80 seconds). 2, 3
During PCI, target activated clotting time (ACT) of 250-350 seconds, or 200-250 seconds if a GP IIb/IIIa inhibitor is administered. 1
Duration of Therapy
Continue parenteral anticoagulation until revascularization (PCI or CABG) is performed. 2
For patients not undergoing an invasive approach, continue for the duration of hospitalization (maximum 8 days). 2
Discontinue immediately after PCI for uncomplicated cases. 1
Alternative Anticoagulants
While UFH with bolus is standard, alternatives exist:
Enoxaparin (LMWH) has shown superiority to UFH in two large trials (ESSENCE and TIMI-11B) and is preferred over UFH unless CABG is planned within 24 hours (Class IIa, Level A). 1
Fondaparinux is recommended when medical treatment is planned or logistical constraints delay PCI transfer, but requires a single UFH bolus at the time of PCI to prevent catheter thrombosis. 1, 2
Bivalirudin may be considered as an alternative to UFH (Class IIb, Level A). 1
Critical Pitfalls to Avoid
Never skip the bolus—the bolus achieves immediate therapeutic anticoagulation while the infusion takes hours to reach steady state. 2, 3
Avoid crossover between UFH and LMWH (Class III, Level B), as this increases bleeding risk without added benefit. 1
Reduce dosing with GP IIb/IIIa inhibitors—use 50-70 IU/kg bolus instead of 70-100 IU/kg to minimize bleeding. 1
Adjust for renal impairment—in patients with CrCl <30 mL/min, UFH is strongly preferred over LMWH due to renal accumulation and unpredictable anticoagulation with LMWH. 5
Excessive anticoagulation increases bleeding risk, particularly when combined with fibrinolytics or GP IIb/IIIa inhibitors. 2